TITLE

Addition of inhaled corticosteroids to long-acting β2-agonists does not improve outcomes in stable COPD

AUTHOR(S)
Aaron, Shawn D.
PUB. DATE
March 2010
SOURCE
ACP Journal Club;3/16/2010, Vol. 152 Issue 3, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a medical research related to effectiveness and safety of inhaled corticosteroids and long-acting β2-agonists (LABA) combined therapy in patients with stable chronic obstructive pulmonary disease (COPD). Combined LABA/ICS therapy reduced risk for moderate COPD exacerbations in comparison of LABA alone and increased the risk of Risks for pneumonia and viral respiratory infections. Combined LABA/ICS therapy is not more effective than LABAs alone.
ACCESSION #
48839866

 

Related Articles

  • Long-Acting β-Agonists With vs Without Inhaled Corticosteroids for COPD. Suissa, Samy; Ernst, Pierre // JAMA: Journal of the American Medical Association;1/20/2015, Vol. 313 Issue 3, p305 

    A letter to the editor is presented in response to an observational study led by Andrea S. Gershon, M.D., which evaluates the long-term outcomes linked with use of long-acting beta-agonists along with inhaled corticosteroids in chronic obstructive pulmonary disease.

  • Management based on partnerships.  // New Zealand Doctor;11/19/2008, p23 

    The article discusses an asthma management plan based on partnerships. The goals of a successful management plan include minimal symptoms, minimal use of rescue medication, and promotion of normal or near-normal lung function. Among the medications that form the backbone of asthma therapy for...

  • Deterioration of COPD.  // Pulse;2/25/2009 Early Treatment of COPD, Vol. 69, p7 

    The article offers information regarding the case of patient with moderate chronic obstructive pulmonary disease. Spirometry showed that patient's FEV1 ratio has significantly declined over the last five years showing a deterioration of disease. It notes that the current treatment of the patient...

  • Treating COPD in the RealWorld. Calverley, Peter M. A. // JAMA: Journal of the American Medical Association;9/17/2014, Vol. 312 Issue 11, p1101 

    An introduction to a study about the efficacy of using long-acting beta-agonists (LABA) alone or in combination with inhaled corticosteroids (ICS) in the treatment of chronic obstructive pulmonary disease (COPD) in elderly patients is presented.

  • Review: corticosteroids plus long-acting βagonists reduce exacerbations more than long-acting β-agonists alone in COPD.  // Evidence Based Medicine;Apr2008, Vol. 13 Issue 2, p57 

    REVIEW PROCESS Question: in patients with stable chronic obstructive pulmonary disease (COPD), how do inhaled corticosteroids (ICSs) combined with long-acting β-agonists (LABAs) compare with LABAs alone? Search methods: Medline, EMBASE/Excerpta Medica, Cochrane Central Register of Controlled...

  • THE USE OF LONG-ACTING β2-AGONISTS AS MONOTHERAPY IN CHILDREN AND ADULTS. Camp, Pat G.; Tingting Zhang; Smith, M. Anne; Carleton, Bruce C. // Journal of Population Therapeutics & Clinical Pharmacology;2013, Vol. 20 Issue 1, pe1 

    Background In asthma, it is recommended that long-acting β2-agonists (LABAs) not be used as monotherapy, but, be used with inhaled corticosteroids (ICS) to minimize the risk of serious adverse events. Objective To test the hypothesis that if clinical recommendations were followed, LABA...

  • Changes in recommended treatments for mild and moderate asthma. Redding, Gregory J.; Stoloff, Stuart W. // Journal of Family Practice;Sep2004, Vol. 53 Issue 9, p692 

    This article reviews the 2002 National Asthma Education and Prevention Program (NAEPP) recommendations for the use of controlled medications for asthma, including the relative effectiveness of inhaled corticosteroids (ICSs) versus other controller medications, safety of long-term ICS use in...

  • COPD combination therapy questioned.  // Independent Nurse;11/2/2009, p15 

    The article discusses a Dutch study concerning the addition of long-acting beta-agonists (LABAs) to corticosteroid therapy for chronic obstructive pulmonary disease (COPD). The findings of the study negate an analysis of the Toxoplasmosis, Rubella, Cytomegalovirus and Herpes Simplex (TORCH)...

  • The WISDOM of inhaled corticosteroids in COPD. Halpin, David M. G.; Quint, Jennifer K. // Thorax;Dec2014, Vol. 69 Issue 12, p1071 

    The article focuses on a study showing the effective role of inhaled corticosteroids (ICS) along with bronchodilators in patients with Chronic obstructive pulmonary disease (COPD) reducing the risk of exacerbations. Topics discussed include WISDOM study conducted to investigate the role of ICS,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics